Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gholamreza Azizi

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Recent Patents on Inflammation & Allergy Drug Discovery|August 17, 2013
Imatinib mesylate: an innovation in treatment of autoimmune diseasesGholamreza Azizi, Abbas Mirshafiey
Immunopharmacology and Immunotoxicology|September 14, 2012
The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesisGholamreza Azizi, Abbas Mirshafiey
American Journal of Alzheimer'S Disease and Other Dementias|January 11, 2014
The Potential Role of Chemokines in Alzheimer's Disease PathogenesisGholamreza Azizi, Nikoo Khannazer, Abbas Mirshafiey
International Journal of Rheumatic Diseases|January 29, 2014
The potential role of angiogenic factors in rheumatoid arthritisGholamreza Azizi, Roobina Boghozian, Abbas Mirshafiey
Innovations in Clinical Neuroscience|September 28, 2016
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple SclerosisNazanin Arjomand Fard, Gholamreza Azizi, Abbas Mirshafiey
International Journal of Rheumatic Diseases|September 3, 2013
Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritisSima Sh Farid, Gholamreza Azizi, Abbas Mirshafiey
International Journal of Rheumatic Diseases|August 29, 2013
Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritisGholamreza Azizi, Farhad Jadidi-Niaragh, Abbas Mirshafiey
Current Opinion in Pediatrics|September 10, 2024
Practical considerations in diagnosing inborn errors of immunity according to the Middle East and North Africa guidelinesIlknur Kulhas Celik, Gholamreza Azizi, Hasibe Artac
Innovations in Clinical Neuroscience|October 23, 2014
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis TherapyAbbas Mirshafiey, Ghasem Ghalamfarsa, Babak Asghari, et al.
Immunopharmacology and Immunotoxicology|March 8, 2014
The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosisMaryam Roozbeh, Hemn Mohammadpour, Gholamreza Azizi, et al.
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Recent Patents on Inflammation & Allergy Drug Discovery|August 17, 2013
Imatinib mesylate: an innovation in treatment of autoimmune diseasesGholamreza Azizi, Abbas Mirshafiey
Immunopharmacology and Immunotoxicology|September 14, 2012
The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesisGholamreza Azizi, Abbas Mirshafiey
American Journal of Alzheimer'S Disease and Other Dementias|January 11, 2014
The Potential Role of Chemokines in Alzheimer's Disease PathogenesisGholamreza Azizi, Nikoo Khannazer, Abbas Mirshafiey
International Journal of Rheumatic Diseases|January 29, 2014
The potential role of angiogenic factors in rheumatoid arthritisGholamreza Azizi, Roobina Boghozian, Abbas Mirshafiey
Innovations in Clinical Neuroscience|September 28, 2016
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple SclerosisNazanin Arjomand Fard, Gholamreza Azizi, Abbas Mirshafiey
International Journal of Rheumatic Diseases|September 3, 2013
Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritisSima Sh Farid, Gholamreza Azizi, Abbas Mirshafiey
International Journal of Rheumatic Diseases|August 29, 2013
Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritisGholamreza Azizi, Farhad Jadidi-Niaragh, Abbas Mirshafiey
Current Opinion in Pediatrics|September 10, 2024
Practical considerations in diagnosing inborn errors of immunity according to the Middle East and North Africa guidelinesIlknur Kulhas Celik, Gholamreza Azizi, Hasibe Artac
Innovations in Clinical Neuroscience|October 23, 2014
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis TherapyAbbas Mirshafiey, Ghasem Ghalamfarsa, Babak Asghari, et al.
Immunopharmacology and Immunotoxicology|March 8, 2014
The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosisMaryam Roozbeh, Hemn Mohammadpour, Gholamreza Azizi, et al.
Pageof 20